{"id":12213,"date":"2025-01-14T18:01:49","date_gmt":"2025-01-14T17:01:49","guid":{"rendered":"https:\/\/valintermed.com\/?p=12213"},"modified":"2025-01-14T18:01:49","modified_gmt":"2025-01-14T17:01:49","slug":"kartsinoma-nosoglotki","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/","title":{"rendered":"Nasopharyngeal carcinoma"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Nasopharyngeal carcinoma is a malignant tumor that occurs in the nasopharynx, which serves as a link between the nasal cavity and the pharynx. This disease is characterized by the inactivation of normal cellular mechanisms, leading to uncontrolled cell division and the formation of a tumor mass. It often occurs in people who are regularly exposed to certain mutagens, such as viruses, chemicals, and tobacco smoke. One of the most common causes of nasopharyngeal carcinoma is infection with the Epstein-Barr virus (EBV), which is considered oncogenic and causes certain changes in the DNA structure of nasopharyngeal cells. In addition, this tumor is more common in men than in women and is characterized by a strong association with certain ethnic groups, especially in Southeast Asia.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/nasal-kartsinoma\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nasopharyngeal carcinoma was known long before the modern oncological understanding of diseases. In the first half of the 20th century, when the first cases of nasopharyngeal carcinoma were discovered, doctors often associated them with chronic diseases such as serous otitis and adenoids. With the discovery of the Epstein-Barr virus in 1964, it became clear that this infectious agent plays a key role in the pathogenesis of the disease. Scientific research confirms the relationship between EBV and nasopharyngeal carcinoma, which became fundamental for the development of new approaches to diagnosis and treatment. Over time, diagnostic and treatment methods have also evolved significantly, moving from simple surgical interventions to a comprehensive approach using radiotherapy and chemotherapy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nasopharyngeal carcinoma is much less common than many other cancers, but its prevalence varies by geographic region. According to the World Health Organization, there are approximately 50,000 new cases worldwide each year, with the highest number of cases occurring in Southeast Asia, particularly in countries such as Thailand and Malaysia. Men are affected three to five times more often than women. The risk of developing nasopharyngeal carcinoma increases significantly between the ages of 50 and 70, although cases can also occur in younger people, especially if they have a genetic predisposition and smoke.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Research shows that genetic predisposition plays a key role in the development of nasopharyngeal carcinoma. Mutations in genes responsible for cell cycle control and cellular apoptosis are considered extremely important. In particular, the following genes are distinguished:<\/p>\n<ul>\n<li><strong>TP53<\/strong> \u2014 a gene encoding the p53 protein, which is important for tumor suppression;<\/li>\n<li><strong>EBER<\/strong> - small RNAs associated with the Epstein-Barr virus;<\/li>\n<li><strong>MYC<\/strong> \u2014 a gene involved in the regulation of cell growth and proliferation;<\/li>\n<\/ul>\n<p>Alterations in these genes can be detected in a significant proportion of patients with nasopharyngeal carcinoma, which highlights the importance of genetic testing in the diagnosis and prognosis of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nasopharyngeal carcinoma is associated with multiple risk factors, which can be divided into physical and chemical. The main risk factors include:<\/p>\n<ul>\n<li><strong>Smoking<\/strong> - is an independent risk factor that increases the likelihood of developing the disease;<\/li>\n<li><strong>Improper nutrition<\/strong> - high consumption of canned and salted fish is associated with increased risk;<\/li>\n<li><strong>Viral infections<\/strong> - especially EBV and human papillomavirus infection;<\/li>\n<li><strong>Heredity<\/strong> - a family history of the disease may indicate a genetic predisposition;<\/li>\n<li><strong>Degree of impact<\/strong> - People working in certain professions are at risk due to exposure to chemical carcinogens.<\/li>\n<\/ul>\n<p>All of the above factors emphasize the need for prevention and early diagnosis of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of nasopharyngeal carcinoma involves several stages and may include:<\/p>\n<ul>\n<li><strong>Main symptoms<\/strong>: patients may complain of prolonged nasal congestion, nosebleeds, sore throat and ear, and voice changes.<\/li>\n<li><strong>Laboratory research<\/strong>: Tissue samples (biopsy) are often taken for histological examination.<\/li>\n<li><strong>Radiological examinations<\/strong>: Computed tomography (CT) and magnetic resonance imaging (MRI) are used to visualize the tumor and assess its extent.<\/li>\n<li><strong>Other types of diagnostics<\/strong>: Endoscopy of the nasopharynx allows obtaining more accurate information about the location and size of the tumor.<\/li>\n<li><strong>Differential diagnosis<\/strong>: Other diseases such as lymphoma and sinusitis must be excluded.<\/li>\n<\/ul>\n<p>An effective approach to diagnosis requires a comprehensive analysis of symptoms and results.<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<p>ov various studies.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of nasopharyngeal carcinoma depends on the stage of the disease and the general condition of the patient. The main treatment methods include:<\/p>\n<ul>\n<li><strong>General treatment<\/strong>: a multidisciplinary approach is used, including therapy with otolaryngologists, radiologists and oncologists;<\/li>\n<li><strong>Pharmacological treatment<\/strong>: chemotherapy is used to destroy cancer cells;<\/li>\n<li><strong>Surgical treatment<\/strong>: in some cases, the tumor can be removed surgically;<\/li>\n<li><strong>Other types of treatment<\/strong>: Radiotherapy is often used as a mainstay of treatment to kill cells at the site of a tumor.<\/li>\n<\/ul>\n<p>Thus, the choice of treatment method depends on many factors, including the stage of the disease and the general health of the patient.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The following groups of drugs are used in the treatment of nasopharyngeal carcinoma:<\/p>\n<ul>\n<li><strong>Cisplatin<\/strong> \u2014 the main chemotherapeutic agent;<\/li>\n<li><strong>Carbotaplatin<\/strong> - an alternative chemotherapeutic agent;<\/li>\n<li><strong>Paclitaxel<\/strong> - used as an adjunctive therapy;<\/li>\n<li><strong>Pembrolizumab<\/strong> - immunotherapy for patients with metastases;<\/li>\n<li><strong>Ronisetron<\/strong> \u2014 an antiemetic drug used during chemotherapy courses.<\/li>\n<\/ul>\n<p>The use of these drugs depends on the individual characteristics of the patient and the stage of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring the condition of a patient with nasopharyngeal carcinoma includes the following steps:<\/p>\n<ul>\n<li><strong>Control stages<\/strong>: regular visits to the doctor for examination and consultation;<\/li>\n<li><strong>Forecast<\/strong>: depends on the stage of the disease, general health condition and response to treatment;<\/li>\n<li><strong>Complications<\/strong>: relapses and complications after treatment, such as dry mouth and difficulty swallowing, are possible.<\/li>\n<\/ul>\n<p>Effective monitoring is important to ensure early detection of undesirable changes in a patient&#039;s health status.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nasopharyngeal carcinoma may present differently depending on the patient&#039;s age group:<\/p>\n<ul>\n<li><strong>Among the younger generation<\/strong>: cases of the disease are usually associated with EBV infection and other viral agents;<\/li>\n<li><strong>In middle-aged people<\/strong>: higher incidence and complex forms of the disease are observed;<\/li>\n<li><strong>In older people<\/strong>: the risk of developing cancer increases, and concomitant diseases may occur, which complicates treatment.<\/li>\n<\/ul>\n<p>Thus, the patient&#039;s age has a dramatic impact on the course and prognosis of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What are the main symptoms of nasopharyngeal carcinoma?<\/strong> The main symptoms include nasal congestion, nosebleeds, sore throat and ear, and voice changes.<\/li>\n<li><strong>Who is at risk for developing this disease?<\/strong> Those at risk include smokers, people with chronic nasopharyngeal diseases, and those with a family history of nasopharyngeal cancer.<\/li>\n<li><strong>How is nasopharyngeal carcinoma diagnosed?<\/strong> Diagnosis includes symptom analysis, biopsy, CT and MRI scans, and endoscopy to visualize the tumor.<\/li>\n<li><strong>What are the treatment approaches for nasopharyngeal carcinoma?<\/strong> Treatment may include surgery, chemotherapy, and radiation therapy, depending on the stage of the disease.<\/li>\n<li><strong>What is the likelihood of relapse after treatment?<\/strong> The likelihood of relapse depends on many factors, including the stage at diagnosis and the quality of treatment, so regular monitoring of the patient&#039;s health is important.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Nasopharyngeal carcinoma is a malignant tumor that occurs in the areas of the nasopharynx, which serves as a link between the nasal cavity and the pharynx. It<\/p>","protected":false},"author":1,"featured_media":21178,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-12213","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=12213"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12213\/revisions"}],"predecessor-version":[{"id":14897,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12213\/revisions\/14897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/21178"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=12213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=12213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=12213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}